Vyvanse

Vyvanse, known scientifically as lisdexamfetamine dimesylate, is a prescribed medication designed primarily for the treatment of attention deficit hyperactivity disorder (ADHD) in both adults and children aged six and older. Additionally, it is effective in addressing moderate to severe binge eating disorder (BED) in adults. This long-acting stimulant operates by enhancing the levels of two key neurotransmitters, dopamine and norepinephrine, within the brain. By doing so, it helps to improve focus, attention, and impulse control for those with ADHD, while also aiding in the management of binge eating behaviors in individuals with BED. Its formulation allows for a gradual release of medication, providing sustained therapeutic effects throughout the day.